NCT00403975View on ClinicalTrials.gov

Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

640

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Dry Eye Disease
Interventions
DRUG

diquafosol tetrasodium ophthalmic solution, 2%

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00403975 - Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease | Biotech Hunter | Biotech Hunter